[1] |
LEI Yajie , GAO Yi , WANG Zhijie , CHENG Xi , YANG Yufei , ZHOU Hongyu , CHEN Lihua , CHEN Yixin , LI Haoran , LI Ziting , WU Xiaohua .
Potential role of lymphadenectomy in patients with ovarian cancer (ⅠC-ⅡA): a retrospective trial
[J]. China Oncology, 2021, 31(8): 740-745.
|
[2] |
LI Haizhou , ZHANG Yanwei , XU Yingjie , YANG Men , ZHANG Lei , HAN Jingjun .
miR-933 inhibits proliferation, migration and invasion of lung cancer cell lines by regulation of KLF6 gene
[J]. China Oncology, 2021, 31(7): 581-588.
|
[3] |
CAO Dalong, ZHU Wenkai, SHI Guohai, ZHANG Hailiang, WANG Ziliang, YE Dingwei.
The influence of PRUNE2 gene point mutation on proliferation, apoptosis, invasion and migration of prostate cancer DU145 cells
[J]. China Oncology, 2021, 31(6): 441-446.
|
[4] |
HUA Qing, SHEN Xuefang, XU Pingbo .
Effect of KLK8 on apoptosis of colorectal cancer cells by regulating EGF and its mechanism
[J]. China Oncology, 2021, 31(5): 383-389.
|
[5] |
CHEN Guo , HAN Pengli , CHEN Keru , LI Mingchuang , ZHANG Qingsong , CHEN Zheng , DONG Hanhua , QIAN Yuejun , LÜ Jing .
Molecular mechanism of miR-19b-3p regulating apoptosis of medullary thyroid cancer cells by targeting MTUS1
[J]. China Oncology, 2021, 31(5): 390-396.
|
[6] |
ZHU Jun, WU Xiaohua.
Leading research progress and prospect of gynecological oncology in 2020
[J]. China Oncology, 2021, 31(4): 250-256.
|
[7] |
LI Ruixiao , TANG Qisheng , MA Shanjin , ZHANG Bo , LI Xuelian , ZHANG Zhiming .
NDRG2 increases bladder cancer cell sensitivity to cisplatin by inhibiting Bcl-2 expression
[J]. China Oncology, 2021, 31(4): 263-267.
|
[8] |
CAI Shumo, TANG Jie, HUANG Xiao, HUANG Xiaowei, LIU Suping, KE Guihao, ZHENG Zhong, CHENG Xi, TANG Meiqin.
Three-step chemotherapy treatment for platinum-sensitive recurrent ovarian cancer: a review of 20 cases
[J]. China Oncology, 2021, 31(4): 330-334.
|
[9] |
LIU Yixuan , WEN Zexuan , GUO Lin , LU Renquan .
The function of TTK1 in platinum-resistant ovarian cancer
[J]. China Oncology, 2021, 31(3): 182-191.
|
[10] |
MA Qian , LIU Yixuan , KAI Jinyan , GUO Lin , LU Renquan .
Down-regulation of Ku86 inhibits cisplatin-induced chemotherapy sensitivity by regulating TOP1 and COPS5 in epithelial ovarian cancer
[J]. China Oncology, 2021, 31(2): 100-107.
|
[11] |
YU Yi, CONG Qing, XU Congjian, JIANG Wei.
The effect of PAFR on cisplatin sensitivity in ovarian cancer cells and its mechanism
[J]. China Oncology, 2021, 31(11): 1063-1071.
|
[12] |
CHEN Shaogeng, HE Rongqi, ZHANG Wanfei, LIN Xianzuan, CHEN Heshan, XU Rongyu.
miR-122-5p inhibits the growth of esophageal cancer cells and transplanted tumors by targeting CREB1
[J]. China Oncology, 2021, 31(1): 35-44.
|
[13] |
ZHU Kaizhong, WANG Tingrui, CHEN Huanxiong, CHEN Tao, ZHONG Zhenhao.
Expression of O-GlcNAc transferase in osteosarcoma and its effect on proliferation and sensitivity to cisplatin
[J]. China Oncology, 2020, 30(9): 682-688.
|
[14] |
WANG Zhihen , MAO Peimin , JIANG Hongyuan , FAN Lingling .
Assessment of the diagnostic value of CPH-I, CA12-5 and HE4 for cancer prediction in women with ovarian masses with papillary projections diagnosed by ultrasound
[J]. China Oncology, 2020, 30(8): 599-604.
|
[15] |
OUYANG Xiaochun , ZOU Yeqing , LI Yumei , DING Xiaobing .
ARHGAP4 promotes growth of hepatocellular carcinoma cells by regulating HK2 expression
[J]. China Oncology, 2020, 30(7): 481-487.
|